Johnson & Johnson (JNJ)

Create an Alert
84.86 -1.50  -1.74%   NYSE Jun 19, 8:00PM BATS Real time Currency in USD

Johnson & Johnson R&D Expense Quarterly:

1.784B for March 31, 2013
View Full Chart

Johnson & Johnson R&D Expense Quarterly Chart

    Johnson & Johnson Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 1.784B
    Dec. 31, 2012 2.331B
    Sept. 30, 2012 1.923B
    June 30, 2012 2.195B
    March 31, 2012 1.645B
    Dec. 31, 2011 2.155B
    Sept. 30, 2011 1.773B
    June 30, 2011 1.882B
    March 31, 2011 1.738B
    Dec. 31, 2010 1.982B
    Sept. 30, 2010 1.657B
    June 30, 2010 1.648B
    March 31, 2010 1.557B
    Dec. 31, 2009 2.213B
    Sept. 30, 2009 1.617B
    June 30, 2009 1.638B
    March 31, 2009 1.518B
    Dec. 31, 2008 2.108B
    Sept. 30, 2008 1.861B
    June 30, 2008 1.936B
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    JNJ R&D Expense Quarterly Benchmarks

    Companies
    Merck 1.907B
    Pfizer 1.80B
    Eli Lilly and Company 1.348B

    JNJ R&D Expense Quarterly Rankings

    Overall 99th percentile
    11 of 16782
    Sector 99th percentile
    7 of 1410 in Healthcare
    Industry 96th percentile
    5 of 135 in Drug Manufacturers - Major

    JNJ R&D Expense Quarterly Range, Past 5 Years

    Minimum 1.518B Mar 2009
    Maximum 2.331B Dec 2012
    Average 1.858B

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');